Cargando…
Analysis of the Ischemia-Modified Albumin as a Potential Biomarker for Cardiovascular Damage in Obstructive Sleep Apnea Patients with Acute Coronary Syndrome
Obstructive sleep apnea (OSA) has been identified as a cardiovascular (CV) risk factor. The potential of OSA promoting the synthesis of CV biomarkers in acute coronary syndrome (ACS) is unknown. Ischemia-modified albumin (IMA) has been identified as a specific CV biomarker. The aim of this study was...
Autores principales: | Resano-Barrio, Pilar, Alfaro, Enrique, Solano-Pérez, Esther, Coso, Carlota, Cubillos-Zapata, Carolina, Díaz-García, Elena, Romero-Peralta, Sofía, Izquierdo-Alonso, Jose Luis, Barbé, Ferran, García-Rio, Francisco, Sánchez-de-la-Torre, Manuel, Mediano, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219184/ https://www.ncbi.nlm.nih.gov/pubmed/37240363 http://dx.doi.org/10.3390/ijms24109019 |
Ejemplares similares
-
Diagnosis and Treatment of Sleep Apnea in Children: A Future Perspective Is Needed
por: Solano-Pérez, Esther, et al.
Publicado: (2023) -
Obstructive Sleep Apnea: Emerging Treatments Targeting the Genioglossus Muscle
por: Mediano, Olga, et al.
Publicado: (2019) -
Prevalence of High Blood Pressure in Pediatric Patients with Sleep-Disordered Breathing, Reversibility after Treatment: The KIDS TRIAL Study Protocol
por: Castillo-García, María, et al.
Publicado: (2022) -
PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea
por: Díaz-García, Elena, et al.
Publicado: (2023) -
Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: Resano-Barrio, María Pilar, et al.
Publicado: (2020)